BIOLINERX     Print Page  Close Window

SEC filings
BIOLINERX LTD. filed this Form 6-K on 06/18/2018
Entire Document

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  BioLineRx Ltd.  
/s/ Philip A. Serlin  
    Philip A. Serlin  
    Chief Executive Officer  
Dated: June 18, 2018